結核患者のための即興薬のパッケージ.

Impact of premorbid nutritional status on TB severity.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025

Sex and age differences in Mycobacterium tuberculosis infection in Brazil.

Epidemiology and infection·2018

Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2006

Tuberculosis in household contacts of infectious cases in Kampala, Uganda.

American journal of epidemiology·2003

Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda.

Journal of clinical microbiology·2002

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.

AIDS (London, England)·2001

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Innovative microneedle-integrated hydrogels: a promising strategy for diabetic foot ulcer management.

Frontiers in bioengineering and biotechnology·2026

A Systematic Review of Three-Dimensional Printing in Medical Education: Educational Impact and Methodological Quality.

Journal of medical education and curricular development·2026

Efficacy differences and predictors of personalized mixed acoustic therapy in chronic tinnitus patients with and without hearing loss.

Frontiers in neurology·2026

Immuno-phage synergy driven by fitness costs: turning bacterial phage resistance into therapeutic gain through evolutionary traps.

Frontiers in immunology·2026

Inhibiting the uPAR/FPR1 interactions reduces blood-retinal barrier breakdown and improves retinal function in a rat model of diabetes.

Frontiers in neuroscience·2026

Nanostructured Surface Modifications for Cardiac Implants: From Bench to Bedside.

Current cardiology reviews·2026

関連する実験動画

結核患者のための即興薬のパッケージ

関連する概念動画

Impact of premorbid nutritional status on TB severity.

Sex and age differences in Mycobacterium tuberculosis infection in Brazil.

Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala.

Tuberculosis in household contacts of infectious cases in Kampala, Uganda.

Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda.

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Innovative microneedle-integrated hydrogels: a promising strategy for diabetic foot ulcer management.

A Systematic Review of Three-Dimensional Printing in Medical Education: Educational Impact and Methodological Quality.

Efficacy differences and predictors of personalized mixed acoustic therapy in chronic tinnitus patients with and without hearing loss.

Immuno-phage synergy driven by fitness costs: turning bacterial phage resistance into therapeutic gain through evolutionary traps.

Inhibiting the uPAR/FPR1 interactions reduces blood-retinal barrier breakdown and improves retinal function in a rat model of diabetes.

Nanostructured Surface Modifications for Cardiac Implants: From Bench to Bedside.

関連する実験動画

結核患者のための即興薬のパッケージ

関連する概念動画

関連記事